Atlas Trials

An Expanded Access Study of Abiraterone Acetate in Patients With Advanced Prostate Cancer Who Have Completed Clinical Study COU-AA-001

Clinical trial NCT01664728 · COMPLETED

Trial details

NCT number
NCT01664728
Sponsor
Janssen Research & Development, LLC
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Prostate Neoplasms
Start date
2007-04-01
Primary completion
2009-02-01
Enrollment
54

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.